Share chart FSD Pharma Inc.
Extended chart
Simple chart
About FSD Pharma Inc.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.Main settings
IPO date | 2018-06-08 |
---|---|
ISIN | CA35954B2066 |
Industry | IT Services |
Sector | Information Technology |
Валюта | usd |
Валюта отчета | usd |
Сайт | link |
Цена ао | 5.39 |
Change price per day: | 0% (5.39) |
---|---|
Change price per week: | 0% (5.39) |
Change price per month: | 0% (5.39) |
Change price per 3 month: | 0% (5.39) |
Change price per half year: | 0% (5.39) |
Change price per year: | +1 462.32% (0.345) |
Change price per 3 year: | +512.5% (0.88) |
Change price per 5 year: | +65.41% (3.2586) |
Change price per year to date: | 0% (5.39) |
Grade
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Main owners
Institutions | Volume | Share, % |
---|---|---|
AdvisorShares Investments, LLC | 270 316 | 0.67 |
Renaissance Technologies, LLC | 69 200 | 0.17 |
Scotia Capital Inc. | 61 273 | 0.15 |
UBS Group AG | 26 362 | 0.07 |
Group One Trading, L.P. | 17 653 | 0.04 |
TWO SIGMA SECURITIES, LLC | 13 584 | 0.03 |
Susquehanna International Group, LLP | 11 791 | 0.03 |
Td Waterhouse Canada Inc. | 10 373 | 0.03 |
Citadel Advisors Llc | 2 483 | 0.01 |
Royal Bank of Canada | 2 450 | 0.01 |
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Zeeshan Saeed | Founder, CEO, President & Executive Co-Chairman | 222.62k | 1970 (55 years) |
Mr. Anthony John Durkacz | Founder & Executive Co-Chairman | 222.62k | 1976 (49 years) |
Mr. Nathan Coyle CPA | Chief Financial Officer | 178.21k | 1981 (44 years) |
Mr. Donal Carroll CPA | Chief Operating Officer | 225.62k | 1977 (48 years) |
Dr. Lakshmi P. Kotra BPHARM, Ph.D. | CEO of Lucid & Director | 144.72k | 1971 (54 years) |
Dr. Andrzej Chruscinski M.D., Ph.D. | Vice President of Clinical & Scientific Affairs of Lucid | 110.3k | |
Mr. Kevin Cassidy | Vice President of Quality-Lucid | 144.82k | |
Ms. Maryann Adesso | Corporate Secretary | N/A | |
Randell Mack | President of FSD BioSciences | N/A |
About company
Address: Canada, Toronto. ON ML A, 199 Bay Street - Open in google maps, Open in yandex maps
Website: https://www.fsdpharma.com
Website: https://www.fsdpharma.com